Centenial Surgic

23
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE405H01018
  • NSEID:
  • BSEID: 531380
INR
81.90
-4.25 (-4.93%)
BSENSE

Aug 14, 04:01 PM

BSE+NSE Vol: 151

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.55% vs -2.78% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 24.61% vs 17.07% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 49.14% vs 48.08% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -229.03% vs 28.04% in Mar 2024

Compare Profit and Loss Results of Centenial Surgic
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
53.00
25.00
28.00
112.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
53.00
25.00
28.00
112.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
16.00
12.00
4.00
33.33%
Power & Fuel Cost
1.00
1.00
0.00
0.00%
Employee Cost
11.00
9.00
2.00
22.22%
Operating Expenses
0.00
2.00
-2.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
0.00
2.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
47.00
28.00
19.00
67.86%
Operating Profit (PBDIT) excl Other Income
6.00
-2.00
8.00
400.00%
Other Income
0.00
5.00
-5.00
-100.00%
Operating Profit (PBDIT)
6.00
3.00
3.00
100.00%
Interest
3.00
2.00
1.00
50.00%
Profit before Depriciation and Tax
2.00
0.00
2.00
0%
Depreciation
4.00
2.00
2.00
100.00%
Profit Before Taxation & Exceptional Items
-1.00
-1.00
0.00
0.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-1.00
-3.00
2.00
66.67%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-1.00
-3.00
2.00
66.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
26.00
-9.00
35.00
388.89%
Profit Available for appropriations
25.00
-13.00
38.00
292.31%
Appropriations
25.00
-13.00
38.00
292.31%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-4.01
-7.08
3.07
43.36%
Profit And Loss - Net Sales
Net Sales 53.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.55% vs -2.78% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 24.61% vs 17.07% in Mar 2024

Profit And Loss - Interest
Interest 3.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 49.14% vs 48.08% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -1.46 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -229.03% vs 28.04% in Mar 2024